Literature DB >> 7186823

Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release.

J S de Belleroche, I M Gardiner.   

Abstract

The action of oxotremorine and acetylcholine on the release of dopamine and acetylcholine from tissue slices of the rat nucleus accumbens was studied. Oxotremorine significantly enhanced the release of [14C]-dopamine evoked by 34 mMK+ and the EC50 for this action was 1.5 X 10(-7)M. A maximal enhancement (30%) for this effect was reached at 2 X 10(-7)M oxotremorine. A further enhancement of dopamine release occurred at concentrations of oxotremorine greater than 10(-4)M. The action of oxotremorine on [14C]-dopamine release was calcium-dependent and blocked by atropine (10(-4) M) but not mecamylamine (up to 10(-4) M). Oxotremorine affected [3H]-acetylcholine release differentially, inhibiting the K+-evoked release of [3H]-acetylcholine at concentrations greater than 10(-5) M. The IC50 for this process was 4.3 X 10(-5) M. Acetylcholine (8 X 10(-4) M) showed a similar pattern of action to oxotremorine: it enhanced the K+-evoked release of [14C]-dopamine (50%) and inhibited the K+-evoked release of [3H]-acetylcholine (30%). The mechanism of action of oxotremorine on dopamine release is discussed in terms of a presynaptic receptor-mediated process.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7186823      PMCID: PMC2071605          DOI: 10.1111/j.1476-5381.1982.tb08794.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Choline acetyltransferase activity and mass fragmentographic measurement of acetylcholine in specific nuclei and tracts of rat brain.

Authors:  D L Cheney; H F LeFevere; G Racagni
Journal:  Neuropharmacology       Date:  1975-11       Impact factor: 5.250

2.  The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1975-05       Impact factor: 4.432

3.  Behavioral effects of local injection of 6-hydroxydopamine in the medial ventral tegmentum in the rat. Possible role of the mesolimbic dopamingergic system.

Authors:  M Le Moal; D Galey; B Cardo
Journal:  Brain Res       Date:  1975-04-25       Impact factor: 3.252

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Drug-induced changes of dopamine turnover in striatum and limbic system of the rat.

Authors:  G Bartholini; H H Keller; A Pletscher
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

6.  Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine.

Authors:  J C Szerb; G T Somogyi
Journal:  Nat New Biol       Date:  1973-01-24

7.  Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.

Authors:  J Christiansen; R F Squires
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

8.  Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens.

Authors:  A J Pijnenburg; J M van Rossum
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

9.  The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections.

Authors:  C C Shute; P R Lewis
Journal:  Brain       Date:  1967-09       Impact factor: 13.501

10.  Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus.

Authors:  M F Giorguieff; M L Le Floc'h; T C Westfall; J Glowinski; M J Besson
Journal:  Brain Res       Date:  1976-04-16       Impact factor: 3.252

View more
  5 in total

1.  Presynaptic modulation of dopamine-induced locomotor activity of oxotremorine in nucleus accumbens of the rat.

Authors:  J S de Belleroche; P Winn; E Murzi; S F Williams; L J Herberg
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

2.  Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens.

Authors:  Jung Hoon Shin; Martín F Adrover; Jürgen Wess; Veronica A Alvarez
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

3.  Muscarinic receptors discriminated by pirenzepine are involved in the regulation of neurotransmitter release in rat nucleus accumbens.

Authors:  J de Belleroche; I M Gardiner
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

4.  Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.

Authors:  R Rivest; C A Marsden
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

5.  Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine.

Authors:  J Grenhoff; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.